FindTrial
Sign In

Follow-up of pediatric immune-mediated central nervous system demyelinating disorders

Follow-up of pediatric immune-mediated central nervous system demyelinating disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900025110
Enrollment
Unknown
Registered
2019-08-11
Start date
2019-09-01
Completion date
Unknown
Last updated
2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

immune-mediated central nervous system demyelinating disorders

Interventions

Case Series:None

Sponsors

Beijing Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. Visiting a doctor or hospitalization in neurologic department of Beijing Children's Hospital. 2. Diagnosed with immune-mediated central nervous system demyelinating disorders. 3. Younger than 18 years.

Exclusion criteria

Exclusion criteria: 1. White matter lesions caused by other causes, such as systemic immune disorders, vasculitis and leukodystrophy. 2. Patients can not follow up regularly.

Design outcomes

Primary

MeasureTime frame
EDSS scores;number,size and enhancement of lesions in MRIs;—

Countries

China

Contacts

Public ContactXiaodun Ren

Beijing Children's Hospital

rxt1997@126.com+86 010 59016351

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026